Selective inhibition of oncogenic ras-p21 in vivo by agents that block its interaction with jun-N-kinase (JNK) and jun proteins. Implications for the design of selective chemotherapeutic agents

AMAR, S ; GLOZMAN, A ; CHUNG, D ; ADLER, V ; RONAI, Z ; FRIEDMAN, F. K ; ROBINSON, R ; BRANDT-RAUF, P ; YAMAIZUMI, Z ; PINCUS, M. R

Cancer chemotherapy and pharmacology, 1997, Vol.41 (1), p.79-85 [Periódico revisado por pares]

Berlin: Springer

Texto completo disponível